Evidence map›Paper›PMID 29376523›Full record

ReviewNature reviews. Endocrinology2018

Osteocalcin in the brain: from embryonic development to age-related decline in cognition.

Arnaud Obri, Lori Khrimian, Gerard Karsenty, Franck Oury

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 1 pooled it
18.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 1 synthesis or guideline pooled it, 224 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. The crossroads between osteosarcopenia and intrinsic capacity-a narrative review.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Review
  5. Article
  6. Degradation of the Molecular Basis of Life During the Aging Process.International journal of molecular sciences · 2026
    Review
  7. Memory difficulty and bone mineral density: The NHANES, 2013-2018.Journal of family medicine and primary care · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Circulating neurodegenerative brain injury markers and hip fracture and fall hospitalizations: the Cardiovascular Health Study.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
    Article
  14. Observational
  15. Review
  16. Osteocalcin and frailty among older women.Aging clinical and experimental research · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Arnaud ObriDepartment of Genetics and Development, Columbia University Medical Center, 701 W 168th St. Rm 1602, New York City, New York 10032, USA.
Lori KhrimianDepartment of Genetics and Development, Columbia University Medical Center, 701 W 168th St. Rm 1602, New York City, New York 10032, USA.
Gerard KarsentyDepartment of Genetics and Development, Columbia University Medical Center, 701 W 168th St. Rm 1602, New York City, New York 10032, USA.
Franck OuryInstitut Necker-Enfants Malades, CS 61431, Paris, France Institut National de la Santé et de la Recherche Médicale, U1151, F-75014 Paris, France Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France.
Columbia University Irving Medical Center · USInstitut Necker Enfants Malades · FR

Funding

Transcriptomic CoreP01AG032959 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gerard Karsenty · 2010 to 2026
$39.7M
Hormones: Molecular Mechanism of Action and FunctionsT32DK007328 · NIDDK · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI KOUSTENI, STAVROULA · 1986 to 2025
$7.8M
Regulation of Glucose Uptake in Osteoblasts by Runx2R01DK104727 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KARSENTY, GERARD · 2015 to 2019
$1.8M
NIA NIH HHS P01 AG032959NIDDK NIH HHS R01 DK104727NIDDK NIH HHS T32 DK007328
6 · The paper itself

Abstract

A remarkable, unexpected aspect of the bone-derived hormone osteocalcin is that it is necessary for both brain development and brain function in the mouse, as its absence results in a profound deficit in spatial learning and memory and an exacerbation of anxiety-like behaviour. The regulation of cognitive function by osteocalcin, together with the fact that its circulating levels decrease in midlife compared with adolescence in all species tested, raised the prospect that osteocalcin might be an anti-geronic hormone that could prevent age-related cognitive decline. As presented in this Review, recent data indicate that this is indeed the case and that osteocalcin is necessary for the anti-geronic activity recently ascribed to the plasma of young wild-type mice. The diversity and amplitude of the functions of osteocalcin in the brain, during development and postnatally, had long called for the identification of its receptor in the brain, which was also recently achieved. This Review presents our current understanding of the biology of osteocalcin in the brain, highlighting the bony vertebrate specificity of the regulation of cognitive function and pointing toward where therapeutic opportunities might exist.

Indexed as

AdolescentAdultAge FactorsAgingAnimalsBone and BonesBrainCognitionCognitive DysfunctionHumansMiceOrganogenesisOsteocalcinSensitivity and SpecificitySpatial LearningOsteocalcin

Identifiers

PMID29376523
PMCPMC5958904
OpenAlexW2787250590

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.